Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol

Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 66; no. 1; p. S257
Main Authors: Usman, Z, Mijočević, H, Karimzadeh, H, Al-Mahtab, M, Bazinet, M, Frishman, D, Vaillant, A, Roggendorf, M
Format: Journal Article
Language:English
Published: 2017
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
DOI:10.1016/S0168-8278(17)30822-X